Advanced Intravenous Therapies Go Where Drug Therapies Can Not
The following is a reproduction of a Millennium Health Centre editorial article which appeared in the Seaway News newspaper in Cornwall, Ontario, Canada. The content is shortened to accommodate a newspaper space allotment. As such, it is not academically cited with references. These are available, so please feel free to email your questions.
Dr. Stephen F. Jones B.Comm., N.D.
Doctor of Naturopathic Medicine
My last column introduced the concept of 'intravenous' therapies. These are individually formulated treatments whereby solutions of various vitamins, minerals, natural chemicals, amino acids (etc.) are injected directly into the bloodstream to quickly and dramatically treat everything from asthma to cancer. While they are well researched and used around the world by hundred's of medical and naturopathic doctors, they are still widely unknown to most doctors and patients. As such, several columns will focus upon some general concepts about these therapies.
This column will illustrate the application of I.V. therapies in the treatment of Alzheimer's disease. Unlike drug therapies, I.V. treatments can help actually remove known causes of this condition, as well as be used to treat its degenerative symptoms.
Let's start with the possible causes. Readers may have heard that aluminum toxicity is widely thought to be a cause of Alzheimer's. As illustration, one Ontario study showed that those coming from communities with higher aluminum concentrations in their municipal water increased their risk of Alzheimer's 2.5 times (Environmetrics, 1995;6:233-8).
So how does this relate to I.V. therapies? The answer is that only I.V. therapies can remove aluminum (and other 'toxic elements' speculated in causing the disease, such as lead and mercury) from a patient's body (a process called chelation therapy). If an Alzheimer's patient is properly tested and found to have such neurotoxic elements in their body, merely treating their symptoms with medications would do nothing to address this potential underlying cause. I.V therapies can be used to remove these recognized causative (and definitely aggravating) factors of the disease, allowing for a better treatment prognosis.
Beyond their use in removing known causes of Alzheimer's, however, I.V. therapies also offer leading edge treatment options.
First, consider the findings of a study published in the Archives of Neurology (1998;55:1449-55). It reported that patients with an increased level of homocysteine in their blood had a 200% increased risk of developing Alzheimer's. I.V. therapies are the most efficient and fastest means to eliminate this blood based protein, should it be found on proper blood tests.
Next, 'free radical' damage must be considered and treated. Researchers believe that 'free radical' damage to the brain's neurons is one way in which Alzheimer's inflicts its damage. Toxic elements like aluminum and lead (etc.), along with some speculated chemical exposures, can cause this 'free radical' damage. With this in mind, Alzheimer's patients often need 'antioxidant' therapies to reverse any 'free radical' damage.
Many are advised to take oral supplements of 'antioxidants' such as Vitamin C, Vitamin E, Coenzyme Q10 (etc.) to provide this antioxidant support. Unfortunately, oral supplements have several limitations. Most notably, you need to be able to actually absorb these and get them to the brain's neurons in sufficient enough dosages to be beneficial.
I.V. therapies avoid such problems by delivering the currently recognized, medical dosages of these critical nutrients directly into the blood stream (and, hence, straight to the brain), bypassing a (likely) impaired intestinal absorption. These dosages simply can not be taken or absorbed orally. The results offer fast, and individually tailored therapy.
Beyond these 'antioxidants', current research indicates that a focus of any Alzheimer's patient treatment should include the intravenous administration of several important nutrients. Such absolutely critical nutrients include Glutathione (which can only be used effectively by intravenous injection - oral pills are not stable), Alpha Lipoic Acid, N-Acetyl Cysteine, Vitamin D, Acetyl-L-Carnitine and several others.
As space does not allow for a proper review of these, I encourage readers to go to the website of the renowned neurologist and Alzheimer's specialist Dr. David Perlmutter M.D. for a more detailed description of these critical medical considerations (www.brainrecovery.com - or buy the book of the same name). Readers can link to this site from my own website.
Alzheimer's is a complicated disease about which we are continuously learning more. The I.V. therapies discussed conceptually here are, in deed, 'leading edge' according to research into the disease. Unfortunately only doctors specially trained in and familiar with their application (and research) should be consulted to discuss these therapies.
Having personally provided these to many patients, I feel obligated to educate patients about these options as 'knowledge is power'.
Best of health to you.
Readers may write the EMC newspaper or email Dr. Jones at email@example.com with any inquiries.